| | | | | |
ARCL ARC Group Acquisition I Corp Class A Ordinary Shares | €8.7266 | +0.20% | €156.17M | €181.21 | |
BRR ProCap Financial, Inc. Common Stock | €1.5615 | -4.57% | €156.11M | €257.75K | |
HUMA Humacyte, Inc. Common Stock | €0.55228 | -1.69% | €155.65M | €2.17M | |
HTLM HomesToLife Ltd Ordinary Shares | €1.6890 | +4.92% | €155.42M | €1.19K | |
| €47.8557 | +1.74% | €155.24M | €47.25K | |
FLC Flaherty & Crumrine Total Return Fund Incorporated | €14.6382 | -0.60% | €155.09M | €17.35K | |
PAAC Proem Acquisition Corp I Ordinary Shares | €8.7539 | -0.09% | €154.97M | €110.84 | |
BNR Burning Rock Biotech Limited American Depositary Shares | €8.1372 | +3.35% | €154.93M | €150.42 | |
LFCR Lifecore Biomedical, Inc. Common Stock | €3.8091 | -2.26% | €154.75M | €67.61K | |
CHEC Chenghe Acquisition III Co. Class A Ordinary Share | €8.9246 | -0.44% | €154.39M | €32.54 | |
| €3.3868 | +2.12% | €154.28M | €67.13K | |
ECBK ECB Bancorp, Inc. Common Stock | €17.5148 | -1.58% | €154.09M | €4.21K | |
TNXP Tonix Pharmaceuticals Holding Corp. | €8.6958 | -6.92% | €153.97M | €486.32K | |
| €7.9877 | +0.67% | €153.85M | €141.53K | |
DHF BNY Mellon High Yield Strategies Fund | €2.0673 | -0.42% | €153.56M | €516.79K | |
